- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 12 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 20 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
PCW.3: 6 residues within 4Å:- Chain A: W.495
- Chain D: F.472, M.474, L.475
- Ligands: POV.5, POV.50
Ligand excluded by PLIPPCW.9: 1 residues within 4Å:- Ligands: POV.5
Ligand excluded by PLIPPCW.10: 5 residues within 4Å:- Chain A: L.332, M.603, L.604, K.607
- Ligands: Y01.1
Ligand excluded by PLIPPCW.13: 4 residues within 4Å:- Chain A: L.338, I.341, M.345
- Ligands: POV.12
Ligand excluded by PLIPPCW.14: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPPCW.22: 6 residues within 4Å:- Chain A: F.472, M.474, L.475
- Chain B: W.495
- Ligands: POV.11, POV.24
Ligand excluded by PLIPPCW.28: 1 residues within 4Å:- Ligands: POV.24
Ligand excluded by PLIPPCW.29: 5 residues within 4Å:- Chain B: L.332, M.603, L.604, K.607
- Ligands: Y01.20
Ligand excluded by PLIPPCW.32: 4 residues within 4Å:- Chain B: L.338, M.345, I.384
- Ligands: POV.31
Ligand excluded by PLIPPCW.33: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPPCW.38: 6 residues within 4Å:- Chain B: F.472, M.474, L.475
- Chain C: W.495
- Ligands: POV.30, POV.40
Ligand excluded by PLIPPCW.44: 1 residues within 4Å:- Ligands: POV.40
Ligand excluded by PLIPPCW.45: 5 residues within 4Å:- Chain C: L.332, M.603, L.604, K.607
- Ligands: Y01.36
Ligand excluded by PLIPPCW.48: 4 residues within 4Å:- Chain C: L.338, I.341, M.345
- Ligands: POV.47
Ligand excluded by PLIPPCW.49: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPPCW.52: 4 residues within 4Å:- Chain D: L.338, I.341, M.345
- Ligands: POV.51
Ligand excluded by PLIPPCW.53: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPPCW.58: 6 residues within 4Å:- Chain C: F.472, M.474, L.475
- Chain D: W.495
- Ligands: POV.46, POV.60
Ligand excluded by PLIPPCW.64: 1 residues within 4Å:- Ligands: POV.60
Ligand excluded by PLIPPCW.65: 5 residues within 4Å:- Chain D: L.332, M.603, L.604, K.607
- Ligands: Y01.56
Ligand excluded by PLIP- 32 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.4: 24 residues within 4Å:- Chain A: R.350, P.351, D.364, N.365, T.366, Q.369, Q.370, K.371, M.435, V.438, M.442, R.443, S.446, A.447, S.448, G.449, E.450, V.452, M.454, F.456
- Chain B: D.550
- Ligands: POV.6, POV.8, POV.19
Ligand excluded by PLIPPOV.5: 18 residues within 4Å:- Chain A: C.494, W.495, A.498, L.502, Y.509, Q.513, D.525, Y.526, P.527, L.530
- Chain D: I.341, I.348, Y.349
- Ligands: PCW.3, PCW.9, POV.19, POV.50, POV.51
Ligand excluded by PLIPPOV.6: 16 residues within 4Å:- Chain A: I.420, V.427, L.428, T.431, F.456, Q.483, K.484, I.486, F.487, G.488, R.584
- Chain B: A.561, I.564
- Ligands: Y01.2, POV.4, POV.19
Ligand excluded by PLIPPOV.7: 16 residues within 4Å:- Chain A: F.343, C.346, C.347, L.373, Q.374, Y.377, L.386, E.389, T.392, V.393, V.436, T.439, M.440, R.443, L.444, M.454
Ligand excluded by PLIPPOV.8: 10 residues within 4Å:- Chain A: F.434, M.435, L.437, V.438, M.442, I.445, S.446, A.447, S.448
- Ligands: POV.4
Ligand excluded by PLIPPOV.11: 16 residues within 4Å:- Chain A: R.326, P.327, C.330, G.333, A.334, L.338, V.465, M.466, F.468, A.469, F.472, Q.473
- Chain B: W.495, L.496
- Ligands: PCW.22, POV.24
Ligand excluded by PLIPPOV.12: 12 residues within 4Å:- Chain A: I.335, I.341, C.342, M.345, Y.349, K.381, I.384, R.385, G.388
- Ligands: Y01.1, PCW.13, POV.24
Ligand excluded by PLIPPOV.16: 11 residues within 4Å:- Chain A: P.552, F.553, I.557, A.560
- Chain D: F.456, M.491
- Ligands: Y01.15, Y01.57, POV.59, POV.60, POV.61
Ligand excluded by PLIPPOV.19: 13 residues within 4Å:- Chain A: V.452, F.456, M.491
- Chain B: P.552, F.553, I.557, A.560, A.561
- Ligands: Y01.2, POV.4, POV.5, POV.6, Y01.18
Ligand excluded by PLIPPOV.23: 23 residues within 4Å:- Chain B: R.350, P.351, D.364, N.365, T.366, Q.369, Q.370, K.371, M.435, V.438, M.442, R.443, S.446, A.447, S.448, G.449, E.450, V.452, M.454
- Chain C: D.550
- Ligands: POV.25, POV.27, POV.35
Ligand excluded by PLIPPOV.24: 18 residues within 4Å:- Chain A: I.341, I.348, Y.349
- Chain B: C.494, W.495, A.498, L.502, Y.509, Q.513, D.525, Y.526, P.527, L.530
- Ligands: POV.11, POV.12, PCW.22, PCW.28, POV.35
Ligand excluded by PLIPPOV.25: 17 residues within 4Å:- Chain B: I.420, L.421, V.427, L.428, T.431, F.456, Q.483, K.484, I.486, F.487, G.488, R.584
- Chain C: A.561, I.564
- Ligands: Y01.21, POV.23, POV.35
Ligand excluded by PLIPPOV.26: 16 residues within 4Å:- Chain B: F.343, C.346, C.347, L.373, Q.374, Y.377, L.386, E.389, T.392, V.393, V.436, T.439, M.440, R.443, L.444, M.454
Ligand excluded by PLIPPOV.27: 10 residues within 4Å:- Chain B: F.434, M.435, L.437, V.438, M.442, I.445, S.446, A.447, S.448
- Ligands: POV.23
Ligand excluded by PLIPPOV.30: 17 residues within 4Å:- Chain B: R.326, P.327, C.330, G.333, A.334, I.335, L.338, V.465, M.466, F.468, A.469, F.472, Q.473
- Chain C: W.495, L.496
- Ligands: PCW.38, POV.40
Ligand excluded by PLIPPOV.31: 13 residues within 4Å:- Chain B: I.335, I.341, C.342, M.345, Y.349, K.381, I.384, R.385, G.388, V.391
- Ligands: Y01.20, PCW.32, POV.40
Ligand excluded by PLIPPOV.35: 11 residues within 4Å:- Chain B: F.456, M.491
- Chain C: P.552, F.553, I.557, A.560
- Ligands: Y01.21, POV.23, POV.24, POV.25, Y01.34
Ligand excluded by PLIPPOV.39: 24 residues within 4Å:- Chain C: R.350, P.351, D.364, N.365, T.366, Q.369, Q.370, K.371, M.435, V.438, M.442, R.443, S.446, A.447, S.448, G.449, E.450, V.452, M.454, F.456
- Chain D: D.550
- Ligands: POV.41, POV.43, POV.55
Ligand excluded by PLIPPOV.40: 20 residues within 4Å:- Chain B: L.337, I.341, I.348, Y.349, V.465
- Chain C: C.494, W.495, A.498, L.502, Y.509, Q.513, D.525, Y.526, P.527, L.530
- Ligands: POV.30, POV.31, PCW.38, PCW.44, POV.55
Ligand excluded by PLIPPOV.41: 16 residues within 4Å:- Chain C: I.420, V.427, L.428, T.431, F.456, Q.483, K.484, I.486, F.487, G.488, R.584
- Chain D: A.561, I.564
- Ligands: Y01.37, POV.39, POV.55
Ligand excluded by PLIPPOV.42: 16 residues within 4Å:- Chain C: F.343, C.346, C.347, L.373, Q.374, Y.377, L.386, E.389, T.392, V.393, V.436, T.439, M.440, R.443, L.444, M.454
Ligand excluded by PLIPPOV.43: 10 residues within 4Å:- Chain C: F.434, M.435, L.437, V.438, M.442, I.445, S.446, A.447, S.448
- Ligands: POV.39
Ligand excluded by PLIPPOV.46: 16 residues within 4Å:- Chain C: R.326, P.327, C.330, G.333, A.334, L.338, V.465, M.466, F.468, A.469, F.472, Q.473
- Chain D: W.495, L.496
- Ligands: PCW.58, POV.60
Ligand excluded by PLIPPOV.47: 11 residues within 4Å:- Chain C: I.335, I.341, C.342, M.345, Y.349, K.381, R.385, G.388
- Ligands: Y01.36, PCW.48, POV.60
Ligand excluded by PLIPPOV.50: 16 residues within 4Å:- Chain A: W.495, L.496
- Chain D: R.326, P.327, C.330, G.333, A.334, L.338, V.465, M.466, F.468, A.469, F.472, Q.473
- Ligands: PCW.3, POV.5
Ligand excluded by PLIPPOV.51: 12 residues within 4Å:- Chain D: I.335, I.341, C.342, M.345, Y.349, K.381, I.384, R.385, G.388
- Ligands: POV.5, PCW.52, Y01.56
Ligand excluded by PLIPPOV.55: 11 residues within 4Å:- Chain C: F.456, M.491
- Chain D: P.552, F.553, I.557, A.560
- Ligands: Y01.37, POV.39, POV.40, POV.41, Y01.54
Ligand excluded by PLIPPOV.59: 24 residues within 4Å:- Chain A: D.550
- Chain D: R.350, P.351, D.364, N.365, T.366, Q.369, Q.370, K.371, M.435, V.438, M.442, R.443, S.446, A.447, S.448, G.449, E.450, V.452, M.454, F.456
- Ligands: POV.16, POV.61, POV.63
Ligand excluded by PLIPPOV.60: 18 residues within 4Å:- Chain C: I.341, I.348, Y.349
- Chain D: C.494, W.495, A.498, L.502, Y.509, Q.513, D.525, Y.526, P.527, L.530
- Ligands: POV.16, POV.46, POV.47, PCW.58, PCW.64
Ligand excluded by PLIPPOV.61: 16 residues within 4Å:- Chain A: A.561, I.564
- Chain D: I.420, V.427, L.428, T.431, F.456, Q.483, K.484, I.486, F.487, G.488, R.584
- Ligands: POV.16, Y01.57, POV.59
Ligand excluded by PLIPPOV.62: 16 residues within 4Å:- Chain D: F.343, C.346, C.347, L.373, Q.374, Y.377, L.386, E.389, T.392, V.393, V.436, T.439, M.440, R.443, L.444, M.454
Ligand excluded by PLIPPOV.63: 10 residues within 4Å:- Chain D: F.434, M.435, L.437, V.438, M.442, I.445, S.446, A.447, S.448
- Ligands: POV.59
Ligand excluded by PLIP- 1 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Neuberger, A. et al., Structural mechanisms of TRPV6 inhibition by ruthenium red and econazole. Nat Commun (2021)
- Release Date
- 2021-11-17
- Peptides
- Transient receptor potential cation channel subfamily V member 6: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 12 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 20 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
- 32 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 1 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Neuberger, A. et al., Structural mechanisms of TRPV6 inhibition by ruthenium red and econazole. Nat Commun (2021)
- Release Date
- 2021-11-17
- Peptides
- Transient receptor potential cation channel subfamily V member 6: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.